Inhaler
Latest Novartis AG Patents:
- NMDA receptor modulators and uses thereof
- Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors
- CD19 and CD22 chimeric antigen receptors and uses thereof
- CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
- ANTI-IgE ANTIBODY THERAPY FOR MULTIPLE FOOD ALLERGIES
Description
The broken lines shown in
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D656606
Type: Grant
Filed: Jun 21, 2011
Date of Patent: Mar 27, 2012
Assignee: Novartis AG (Basel)
Inventors: John Palmer-Felgate (Horsham), Steven Dudley (Horsham), Shimi Barr (Randwick)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Design IP
Application Number: 29/394,724
Type: Grant
Filed: Jun 21, 2011
Date of Patent: Mar 27, 2012
Assignee: Novartis AG (Basel)
Inventors: John Palmer-Felgate (Horsham), Steven Dudley (Horsham), Shimi Barr (Randwick)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Design IP
Application Number: 29/394,724
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)